- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Uralkali Eyes Control of Belaruskali
Reuters reported that Uralkali (LON:URKA) is seeking a valuation of Belaruskali as it considers a bid for control of the company.
Reuters reported that Uralkali (LON:URKA) is seeking a valuation of Belaruskali as it considers a bid for control of the company.
The market news is quoted as saying:
“The obvious option for an acquisition is Belaruskali, although for the moment it is not for sale,” [Chief Executive Vladislav] Baumgertner said at the Reuters Russia Investment Summit. “From a strategic point of view Belaruskali is a very attractive target for us, but it is not a public company and therefore hard to make a valuation. We do not have enough information to make a valuation. If we decide to buy, it will be a controlling stake of course,” he told Reuters Insider Television at the summit, held at the Reuters office in Moscow.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.